Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry

Standard

Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry. / Iliadis, Christos; Baldus, Stephan; Kalbacher, Daniel; Boekstegers, Peter; Schillinger, Wolfgang; Ouarrak, Taoufik; Zahn, Ralf; Butter, Christian; Zuern, Christine S; von Bardeleben, Ralph Stephan; Senges, Jochen; Bekeredjian, Raffi; Eggebrecht, Holger; Pfister, Roman.

in: EUR J HEART FAIL, Jahrgang 22, Nr. 7, 07.2020, S. 1202-1210.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Iliadis, C, Baldus, S, Kalbacher, D, Boekstegers, P, Schillinger, W, Ouarrak, T, Zahn, R, Butter, C, Zuern, CS, von Bardeleben, RS, Senges, J, Bekeredjian, R, Eggebrecht, H & Pfister, R 2020, 'Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry', EUR J HEART FAIL, Jg. 22, Nr. 7, S. 1202-1210. https://doi.org/10.1002/ejhf.1820

APA

Iliadis, C., Baldus, S., Kalbacher, D., Boekstegers, P., Schillinger, W., Ouarrak, T., Zahn, R., Butter, C., Zuern, C. S., von Bardeleben, R. S., Senges, J., Bekeredjian, R., Eggebrecht, H., & Pfister, R. (2020). Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry. EUR J HEART FAIL, 22(7), 1202-1210. https://doi.org/10.1002/ejhf.1820

Vancouver

Bibtex

@article{29b4bba899d84bda9c83c8d10fe32ffd,
title = "Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry",
abstract = "BACKGROUND: Left atrial (LA) dimension is a marker of disease severity and outcome in primary and secondary mitral regurgitation. In transcatheter mitral valve repair, LA enlargement might additionally impact on device handling and technical success through an altered anatomy and atrial annular dilatation.METHODS AND RESULTS: Data from the multicentre German TRAnscatheter Mitral valve Interventions registry (TRAMI) were used to analyse the association of baseline LA diameter by tertiles with efficacy, safety and long-term clinical outcome in patients undergoing edge-to-edge repair with MitraClip. In 520 of 843 patients prospectively enrolled in TRAMI, baseline LA diameter were reported [median (interquartile range) LA diameter in tertiles: 44 (40-46) mm, 51 (48-53) mm and 60 (55-66) mm]. Larger LA diameters were significantly associated with secondary aetiology of mitral regurgitation, lower ejection fraction, larger left ventricle, male sex and atrial fibrillation (all P < 0.05). Technical success was not different across tertiles (96%, 95.4% and 98.4%, respectively; P = 0.43) as were major in-hospital cardiovascular and cerebral adverse events (mortality, myocardial infarction or stroke: 1.8%, 1.2% and 4.4%, respectively; P = 0.11 across tertiles). However, 4-year mortality significantly increased with larger LA diameter (32.9%, 46.4% and 51.7%, respectively; P < 0.01), as did hospitalization in survivors (60%, 67.6% and 78.9%, respectively; P < 0.05). The association between LA diameter and outcome remained significant after multivariable adjustment including baseline left ventricular end-diastolic diameter.CONCLUSION: Left atrial enlargement is a strong and independent predictor of adverse long-term outcome after transcatheter mitral valve repair. Further study is warranted to examine whether timely intervention may have the potential to modify outcome.",
keywords = "Cardiac Catheterization, Female, Heart Failure, Heart Valve Prosthesis Implantation, Humans, Male, Mitral Valve/diagnostic imaging, Mitral Valve Insufficiency/epidemiology, Registries, Treatment Outcome",
author = "Christos Iliadis and Stephan Baldus and Daniel Kalbacher and Peter Boekstegers and Wolfgang Schillinger and Taoufik Ouarrak and Ralf Zahn and Christian Butter and Zuern, {Christine S} and {von Bardeleben}, {Ralph Stephan} and Jochen Senges and Raffi Bekeredjian and Holger Eggebrecht and Roman Pfister",
note = "{\textcopyright} 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.",
year = "2020",
month = jul,
doi = "10.1002/ejhf.1820",
language = "English",
volume = "22",
pages = "1202--1210",
journal = "EUR J HEART FAIL",
issn = "1388-9842",
publisher = "Oxford University Press",
number = "7",

}

RIS

TY - JOUR

T1 - Impact of left atrial diameter on outcome in patients undergoing edge-to-edge mitral valve repair: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) registry

AU - Iliadis, Christos

AU - Baldus, Stephan

AU - Kalbacher, Daniel

AU - Boekstegers, Peter

AU - Schillinger, Wolfgang

AU - Ouarrak, Taoufik

AU - Zahn, Ralf

AU - Butter, Christian

AU - Zuern, Christine S

AU - von Bardeleben, Ralph Stephan

AU - Senges, Jochen

AU - Bekeredjian, Raffi

AU - Eggebrecht, Holger

AU - Pfister, Roman

N1 - © 2020 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

PY - 2020/7

Y1 - 2020/7

N2 - BACKGROUND: Left atrial (LA) dimension is a marker of disease severity and outcome in primary and secondary mitral regurgitation. In transcatheter mitral valve repair, LA enlargement might additionally impact on device handling and technical success through an altered anatomy and atrial annular dilatation.METHODS AND RESULTS: Data from the multicentre German TRAnscatheter Mitral valve Interventions registry (TRAMI) were used to analyse the association of baseline LA diameter by tertiles with efficacy, safety and long-term clinical outcome in patients undergoing edge-to-edge repair with MitraClip. In 520 of 843 patients prospectively enrolled in TRAMI, baseline LA diameter were reported [median (interquartile range) LA diameter in tertiles: 44 (40-46) mm, 51 (48-53) mm and 60 (55-66) mm]. Larger LA diameters were significantly associated with secondary aetiology of mitral regurgitation, lower ejection fraction, larger left ventricle, male sex and atrial fibrillation (all P < 0.05). Technical success was not different across tertiles (96%, 95.4% and 98.4%, respectively; P = 0.43) as were major in-hospital cardiovascular and cerebral adverse events (mortality, myocardial infarction or stroke: 1.8%, 1.2% and 4.4%, respectively; P = 0.11 across tertiles). However, 4-year mortality significantly increased with larger LA diameter (32.9%, 46.4% and 51.7%, respectively; P < 0.01), as did hospitalization in survivors (60%, 67.6% and 78.9%, respectively; P < 0.05). The association between LA diameter and outcome remained significant after multivariable adjustment including baseline left ventricular end-diastolic diameter.CONCLUSION: Left atrial enlargement is a strong and independent predictor of adverse long-term outcome after transcatheter mitral valve repair. Further study is warranted to examine whether timely intervention may have the potential to modify outcome.

AB - BACKGROUND: Left atrial (LA) dimension is a marker of disease severity and outcome in primary and secondary mitral regurgitation. In transcatheter mitral valve repair, LA enlargement might additionally impact on device handling and technical success through an altered anatomy and atrial annular dilatation.METHODS AND RESULTS: Data from the multicentre German TRAnscatheter Mitral valve Interventions registry (TRAMI) were used to analyse the association of baseline LA diameter by tertiles with efficacy, safety and long-term clinical outcome in patients undergoing edge-to-edge repair with MitraClip. In 520 of 843 patients prospectively enrolled in TRAMI, baseline LA diameter were reported [median (interquartile range) LA diameter in tertiles: 44 (40-46) mm, 51 (48-53) mm and 60 (55-66) mm]. Larger LA diameters were significantly associated with secondary aetiology of mitral regurgitation, lower ejection fraction, larger left ventricle, male sex and atrial fibrillation (all P < 0.05). Technical success was not different across tertiles (96%, 95.4% and 98.4%, respectively; P = 0.43) as were major in-hospital cardiovascular and cerebral adverse events (mortality, myocardial infarction or stroke: 1.8%, 1.2% and 4.4%, respectively; P = 0.11 across tertiles). However, 4-year mortality significantly increased with larger LA diameter (32.9%, 46.4% and 51.7%, respectively; P < 0.01), as did hospitalization in survivors (60%, 67.6% and 78.9%, respectively; P < 0.05). The association between LA diameter and outcome remained significant after multivariable adjustment including baseline left ventricular end-diastolic diameter.CONCLUSION: Left atrial enlargement is a strong and independent predictor of adverse long-term outcome after transcatheter mitral valve repair. Further study is warranted to examine whether timely intervention may have the potential to modify outcome.

KW - Cardiac Catheterization

KW - Female

KW - Heart Failure

KW - Heart Valve Prosthesis Implantation

KW - Humans

KW - Male

KW - Mitral Valve/diagnostic imaging

KW - Mitral Valve Insufficiency/epidemiology

KW - Registries

KW - Treatment Outcome

U2 - 10.1002/ejhf.1820

DO - 10.1002/ejhf.1820

M3 - SCORING: Journal article

C2 - 32246804

VL - 22

SP - 1202

EP - 1210

JO - EUR J HEART FAIL

JF - EUR J HEART FAIL

SN - 1388-9842

IS - 7

ER -